Oct 2026· Small· pp.
e76032
· 0 citations· 53 references
Medicine
TL;DR
An injectable, photo-crosslinkable carboxymethyl chitosan (CMCS)-based hydrogel was engineered to achieve localized, synergistic chemo-immunotherapy within the surgical cavity, offering a potent solution to combat malignant glioma recurrence.
Abstract
The inevitable recurrence of glioblastoma multiforme post-resection is primarily driven by infiltrative residual cells and a profoundly immunosuppressive tumor microenvironment (TME) that evades innate immune surveillance. In the present study, an injectable, photo-crosslinkable carboxymethyl chitosan (CMCS)-based hydrogel (si-HAX1&Quercetin@Gel) was engineered to achieve localized, synergistic chemo-immunotherapy within the surgical cavity. The findings demonstrate that the localized release of si-HAX1 triggers robust endoplasmic reticulum stress-mediated immunogenic cell death, leading to significant CRT surface translocation. Concurrently, Quercetin acts as a small-molecule antagonist of the CD47-signal regulatory protein α axis, dismantling the "don't eat me" shield that protects glioma cells from macrophage-mediated phagocytosis. In an in vivo postoperative glioblastoma model, the si-HAX1&Quercetin@Gel effectively suppressed tumor regrowth, increased the M1/M2 macrophage ratio and recruited CD8+ T cells, thereby extending median survival time. Moreover, this localized intervention sensitized residual tumors to intratumorally administered anti-programmed cell death protein 1 therapy by upregulating IFN-γ and remodeling the TME. By integrating biomaterial engineering with deep molecular targeting of HAX1 and CD47, we provide a robust strategy to transform the post-surgical cavity into an active immunological zone, offering a potent solution to combat malignant glioma recurrence.
Osteosarcoma is the most common primary malignant bone tumor in adolescents, significantly impacting their quality of life. The difficulty in removing all residual tumor cells during surgery contributes to the recurrence of osteosarcoma. To provide an alternative strategy, we developed an iron-based polysaccharide hy...
Photodynamic therapy (PDT) can elicit antitumor immunity by inducing immunogenic cell death (ICD), making it an attractive option for postoperative local cancer treatment. However, in solid tumors, aberrant vasculature and an immunosuppressive microenvironment often restrict immune-cell infiltration, thereby weakening...
Radiofrequency ablation (RFA) is a locoregional therapy for hepatocellular carcinoma (HCC). However, the long-term efficacy for RFA is severely compromised by recurrence driven by an immunosuppressive tumor microenvironment (TME). In this study, we identify mature regulatory dendritic cells (mregDCs) as a key immune-re...
Man Luo, Sui Zheng, Wan-Rong Luo et al.· Journal of Controlled Releas...· 0 citations
PM@(M/B)NM is position as a safe and promising biomimetic platform to improve immunotherapy responsiveness in TNBC and unleashing robust anti-tumor immunity.
Mei Ma, Long Tian, Zhi-Qiang Hu et al.· International journal of pha...· 0 citations
GalNAc-modified extracellular vesicles (EVs) derived from hypoxic pancreatic cancer cells and loaded with ANXA2 siRNA were developed to modulate the immunosuppressive tumor microenvironment (TME). Characterization confirmed successful surface modification and efficient siRNA loading in EVs with a diameter of approximat...
Dong-Mei Ren, Fei Lu, Guang-Nian Zhang et al.· Journal of drug targeting (P...· 0 citations